Those in the know – doctors , advocates and pharma insiders – believe the national rare diseases policy needs an urgent rethinkIn Delhi’s CR Park, Prakhar greets you cheerfully at the door.
).Not everyone needs drugs that are as costly but treatment for rare conditions is expensive wherever there is medication available.
"In the December hearing, the health ministry backed out of the health policy.
"Under the Make in India programme, we should have a special programme for rare diseases, so that we can actually produce quality drugs for the diseases.
"We have belief in the government and the health policy.